TROV : Summary for TrovaGene, Inc. - Yahoo Finance

U.S. Markets closed

TrovaGene, Inc. (TROV)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.10+0.10 (+10.00%)
At close: 4:00PM EDT

1.10 0.00 (0.00%)
After hours: 5:25PM EDT

People also watch
IDRASGYPBIOCTRVNVSTM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.00
Open1.05
Bid1.00 x 5000
Ask1.15 x 12600
Day's Range1.05 - 1.10
52 Week Range0.95 - 6.67
Volume122,439
Avg. Volume320,550
Market Cap34.06M
Beta0.57
PE Ratio (TTM)-0.80
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 hours ago

    ETFs with exposure to TrovaGene, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Trovagene to Present at The MicroCap Conference on April 4, 2017 in New York City
    PR Newswire11 hours ago

    Trovagene to Present at The MicroCap Conference on April 4, 2017 in New York City

    SAN DIEGO, March 27, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced that its Chief Executive Officer, Bill Welch, will be presenting at ...

  • TrovaGene, Inc. :TROV-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube6 days ago

    TrovaGene, Inc. :TROV-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis TrovaGene, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of TrovaGene, Inc. – Genomic Health, Inc., Biocept, Inc., Laboratory Corporation of America Holdings, Exact Sciences Corporation, Quest Diagnostics Incorporated, PerkinElmer, Inc., Enzo Biochem, Inc. and QIAGEN NV (GHDX-US, BIOC-US, ... Read more (Read more...)